These results may be explained by the fact that in this metabolic pathway, IDO transforms tryptophan into kynurenine metabolites, such as 3-hydroxy-kynurenine, which has been related to oxidative stress increasing the production of ROS, which may compromise depression status [302]. Here, IDO1 is linked to depressive symptom measurement.